Immunic IMUX
NASDAQ IMUX
$13.11 +0.35 (+2.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Immunic (IMUX) Property, Plant & Equipment (Net) (2013 - 2026)

Analysis

Immunic (IMUX) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Immunic 546.30 Mn 546.30 Mn - 771,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 771,000.00
Mar 31, 2026 566,000.00
Dec 31, 2025 608,000.00
Sep 30, 2025 640,000.00
Jun 30, 2025 612,000.00
Mar 31, 2025 572,000.00
Dec 31, 2024 545,000.00
Sep 30, 2024 618,000.00
Jun 30, 2024 585,000.00
Mar 31, 2024 442,000.00
Dec 31, 2023 466,000.00
Sep 30, 2023 288,000.00
Jun 30, 2023 290,000.00
Mar 31, 2023 288,000.00
Dec 31, 2022 294,000.00
Sep 30, 2022 159,000.00
Jun 30, 2022 139,000.00
Mar 31, 2022 155,000.00
Dec 31, 2021 152,000.00
Sep 30, 2021 196,000.00